EPHA2 and esophageal squamous cell carcinoma: For example, whole-exome sequencing (WES) studies of paired esophageal squamous cell carcinoma (ESCC) tumors before and after radiotherapy revealed that the rate of EphA2 mutations was reduced after treatment, suggesting the need for functioning EphA2 for radio-resistance [125].